Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

RVMD holding history

Revolution Medicines, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVMD overviewAll 13F holders of RVMDFull Q2 2026 holdings

Shares (Q2 2026)
5,448,364
Value
$1.02B
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of RVMD by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,448,364$1.02B0.2%+1,061,573+24.2%AddedHolders
Q1 20264,386,791$426.6M0.1%+1,298,854+42.1%AddedHolders
Q4 20253,087,937$246.0M<0.1%+1,998,972+183.6%AddedHolders
Q3 20251,088,965$50.9M<0.1%+574,212+111.6%AddedHolders
Q2 2025514,753$18.9M<0.1%+32,646+6.8%AddedHolders
Q1 2025482,107$17.0M<0.1%+182,324+60.8%AddedHolders
Q4 2024299,783$13.1M<0.1%+106,704+55.3%AddedHolders
Q3 2024193,079$8.76M<0.1%−24,684−11.3%ReducedHolders
Q2 2024217,763$8.45M<0.1%−87,216−28.6%ReducedHolders
Q1 2024304,979$9.83M<0.1%−1,579−0.5%ReducedHolders
Q4 2023306,558$8.79M<0.1%+209,399+215.5%AddedHolders
Q3 202397,159$2.69M<0.1%−39,295−28.8%ReducedHolders
Q2 2023136,454$3.65M<0.1%−1,907−1.4%ReducedHolders
Q1 2023138,361$3.00M<0.1%−29,282−17.5%ReducedHolders
Q4 2022167,643$3.99M<0.1%+134,940+412.6%AddedHolders
Q3 202232,703$645.0K<0.1%−8,329−20.3%ReducedHolders
Q2 202241,032$800.0K<0.1%−49,117−54.5%ReducedHolders
Q1 202290,149$2.30M<0.1%−24,271−21.2%ReducedHolders
Q4 2021114,420$2.88M<0.1%−2,930−2.5%ReducedHolders
Q3 2021117,350$3.23M<0.1%+116,252+10,587.6%AddedHolders
Q2 20211,098$35.0K<0.1%−340−23.6%ReducedHolders
Q1 20211,438$66.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.